ロード中...

Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease

The purpose of this article is to review eliglustat tartrate, a substrate reduction therapy, for the treatment of Gaucher disease type 1 (GD1). GD is an rare inborn error of metabolism caused by accumulation of lipid substrates such as glucosylceramide within the monocyte-macrophage system that affe...

詳細記述

保存先:
書誌詳細
出版年:Drug Des Devel Ther
主要な著者: Bennett, Lunawati L, Turcotte, Kelsey
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4554398/
https://ncbi.nlm.nih.gov/pubmed/26345314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S77760
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!